Clinicaltrials.gov identifier:
NCT03729115
Surveys, Registries, Interviews
Screening study for women at risk for breast cancer due to an inherited mutation or other risk factor
Study Contact Information:
For additional information, please contact: the Cancer Clinical Intake Office by phone 1-855-702-8222 or by email [email protected]
A Surveillance Program for Women at High Risk for Breast Cancer (CAPSBRACA)
About the Study
This study will create a registry of women at high risk of breast cancer. A registry collects data about specific populations to understand them better. This study will also look at whether an abbreviated works as well as a full for screening women at high risk of breast cancer. An uses strong magnetic fields to create images of the organs in the body and can be used for breast cancer detection and diagnosis. A full consists of many images whereas an abbreviated uses only the most important images.
What the Study Involves
All participants will have:
- A full every 6 months (twice a year)
- A once a year
Study Sites
Illinois
University Of Chicago Medicine Comprehensive Cancer Center
Chicago, Illinois
Contact: Cancer Clinical Trials Intake at 855-702-8222 or by email at [email protected]
Women 25 years and older who:
- Have a known , , , , , or mutation
- OR are otherwise high risk based on their lifetime risk of developing breast cancer and other factors
- Are willing to travel to the University of Chicago Medicine for all study related activities
- Are able to give informed consent
Participants who do not meet the inclusion criteria defined above and those who:
- Are undergoing active cancer treatment
- Are pregnant or want to get pregnant within two years of enrolling
- Have a pacemaker or any other metallic object in their body that interferes with an
- Have had breast surgery within two weeks of enrollment
- Have had a double mastectomy
- Have kidney disease or abnormal kidney function
- Have a history of dye allergy that cannot be controlled with medication